Photo: Reuters
South Korea Approves country's First Domestically Produced COVID-19 Vaccine 'SKYcovione'
South Korea has approved the country's first domestically developed COVID-19 vaccine for administering, on June 29. The country's health ministry said that the domestically produced SKYcovione vaccine builds more immunity than the broadly used AtraZeneca vaccine. The SKYcovione is a two-shot vaccine, which is produced by SK Bioscience, and can now be administered for adults above 18 years of age.
Tags: SKYcovione, Homemade Vaccine, South Korea, Covid-19, AstraZeneca
Courtesy: Hindustan Times
Photo: The Times of India
Booster Dose Not Required For Fully Vaccinated People: Dame Sarah Gilbert
Amid the UK government is planning to inoculate booster shots to citizens, professor Dame Sarah Gilbert, one of the creators of AstraZeneca or Covishied vaccine, has said the shots aren't required for all the fully vaccinated people. The booster dose should be given to those who've weak immunity systems and senior citizens, Gilbert advised. The government should supply vaccines to poor countries to increase vaccination rates, she added.
Tags: Covid-19, Booster Dose, AstraZeneca, Week Immunity, UK
Courtesy: The Print
Photo: Reuters
Japan To Strengthen Diplomatic Relation; Sends One Million COVID-19 Vaccine
Japan is sending one million doses of COVID-19 vaccines to Vietnam, as announced on June 15 by the Japanese Foreign Minister Toshimitsu Motegi. However, the AstraZeneca vaccines are being manufactured in Japan and will reach Vietnam on June 16. To strengthen its diplomatic relations in the world, Japan is planing to send COVID vaccines to other countries including Indonesia, Malaysia, Philippines and Thailand as well.
Tags: Covid-19 Vaccine, Japan, Taiwan, Vietnam, AstraZeneca
Courtesy: WION News
Photo: Times of India
Over 96% People In UK Developed Antibodies After 1st COVID Jab: Study
A study conducted in England and Wales revealed that 96.42% of people administered with first COVID jab developed antibodies in 28-34 days. The study was conducted on 8,517 people who were administered with Pfizer or Astra-Zeneca (Covishield) vaccine. Whereas, in people administered with the second dose it was found that 99.08% of them have progressed antibodies in 7-14 days. The University College London researchers claimed effective of both… read-more
Tags: Covid-19, Vaccination Drive, AstraZeneca, Pfizer, England
Courtesy: WION News
Photo: Business Standard
Joe Biden Adds Extra 20Mn Vaccine Doses For Global Supply
The US government has extended its global vaccine supply quota to 80 million as President Joe Biden on May 17 announced an additional 20 million doses. Notably, 60 million AstraZeneca vaccines doses were approved earlier. The entirety of the doses will be supplied within next six weeks and it will include Pfizer-BioNTech, Moderna and Johnson & Johnson's vaccines as well. Currently, the vaccine doses are awaiting safety clearances.
Tags: Joe BIden, Vaccine Supply, AstraZeneca, Pfizer-BioNTech, Moderna, Johnson&Johnson
Courtesy: The Hindu
Photo: BBC
Sri Lanka: 6 Cases Of Blood Clots Reported In AstraZeneca Jab Recipients
Sri Lankan authorities on April 21 reported six blood clot cases among Indian vaccine AstraZeneca recipients of which three died due to complications. The information was tabled by Lankan Health Minister Pavithra Waniarachchi in parliament. Reportedly, no announcement of halt has been made on the vaccination program. So far nearly one million people have received the first dose of the Indian vaccine in Sri Lanka.
Tags: AstraZeneca, Sri Lanka, India, Health Ministry
Courtesy: The Economic Times
Photo: India .com
SL Rejects Chinese COVID Vaccine Gift; Prefers Russian, Indian Doses
Sri Lankan government has rejected the Chinese Sinopharm vaccine despite of Beijing's claim to have donated more number of vaccines than India. The Lankan cabinet on April 20 announced that while 13.5M doses of Indian-made AstraZeneca have been ordered, it will buy 6M doses of Russian vaccine Sputnik V. Saying that it had already received enough vaccines for its targeted population, Lanka disapproved the use of 600,000 Sinopharm vaccines.
Tags: China, Sri Lanka, Coronavirus Vaccines, AstraZeneca
Courtesy: The Economic Times
Photo: Business Standard
AstraZeneca Sends Legal Notice To SII Over Delays In Vaccine Supply
British-Swedish pharmaceutical company AstraZeneca has served a legal notice to the Serum Institute of India over delays in the supply of COVID-19 vaccine Covishield. SII CEO Adar Poonawalla said, “Serum Institute is not able to fulfil (contractual obligations) due to its prioritisation of Indian supplies." Moreover, denying to comment on the notice and terming it "confidential", Poonawalla said the company is trying to resolve and manage the… read-more
Tags: COVISHIELD, Adar Poonawalla, SII, AstraZeneca
Courtesy: NDTV
Photo: CBS News
Ghana 1st Country To Receive COVAX Vaccines; Gets 6L Jabs From India
West-African country Ghana became the first country to obtain vaccines under the COVAX initiative as it welcomed 6,00,000 doses of the AstraZeneca vaccine by Serum Institute of India on February 24. Delivered by UNICEF, the vaccines reached Ghana’s Kotoka International Airport as part of the initial wave of COVID-19 vaccines that COVAX is granting to 92 low/middle-income nations. Reportedly, Ghana’s will commence its phased vaccination drive… read-more
Tags: Ghana, COVAX, UNICEF, Serum Institute of India, AstraZeneca, Covid -19, vaccine
Courtesy: The Hindu
Photo: The Print
S. Africa Asks Serum Institute To Take Back AstraZeneca COVID Vaccine
The South African government has requested the Serum Institute of India to withdraw one million shots of its COVID-19 vaccine 'AstraZeneca'. The country has reportedly stopped the rollout of the vaccine after finding it provided only mild to moderate protection against the African variant of coronavirus. Moreover, South Africa will now use Johnson & Johnson’s vaccine for its health workers. Recently, on February 15, the WHO gave emergency… read-more
Tags: Covid Vaccine, Serum Institute of India, South Africa, AstraZeneca
Courtesy: The Wire
